Clinical trials
Multiple Sclerosis, Chronic Progressive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
104 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 11 |
| 2025 | 7 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Recruiting | 18 |
| Active, not recruiting | 13 |
| Terminated | 9 |
| Not yet recruiting | 5 |
| Unknown status | 4 |
| Suspended | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 7 |
| Novartis Pharmaceuticals | 6 |
| Johns Hopkins University | 5 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| Shirley Ryan AbilityLab | 4 |
| State University of New York at Buffalo | 4 |
| Biogen | 3 |
| Novartis | 3 |
| University of California, San Francisco | 3 |
| Genentech, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 104 |
| Multiple Sclerosis | 60 |
| Multiple Sclerosis, Relapsing-Remitting | 32 |
| Autoimmune Diseases | 6 |
| Demyelinating Diseases | 5 |
| Fatigue | 4 |
| Autoimmune Diseases of the Nervous System | 3 |
| Hypoxia | 3 |
| Nervous System Diseases | 3 |
| Disease Progression | 2 |
Trials
Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.
4 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.